Michael Petusky
Stock Analyst at Barrington Research
(3.57)
# 933
Out of 4,558 analysts
126
Total ratings
52.46%
Success rate
3.41%
Average return
Main Sectors:
Stocks Rated by Michael Petusky
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| LFCR Lifecore Biomedical | Downgrades: Market Perform | n/a | $4.84 | - | 6 | Aug 28, 2024 | |
| USPH U.S. Physical Therapy | Maintains: Outperform | $122 → $108 | $83.64 | +29.12% | 12 | Aug 15, 2024 | |
| VRME VerifyMe | Maintains: Outperform | $2 → $1.5 | $1.34 | +11.94% | 7 | Aug 14, 2024 | |
| HAE Haemonetics | Maintains: Outperform | $107 → $108 | $73.94 | +46.06% | 24 | Aug 9, 2024 | |
| ANIK Anika Therapeutics | Maintains: Outperform | $37 | $24.59 | +50.47% | 9 | Aug 9, 2024 | |
| MODV ModivCare | Upgrades: Outperform | $35 | $30.00 | +16.67% | 8 | Aug 9, 2024 | |
| OPK OPKO Health | Maintains: Outperform | $1.5 → $2.25 | $1.59 | +41.51% | 5 | Aug 8, 2024 | |
| HSIC Henry Schein | Maintains: Outperform | $92 → $82 | $67.55 | +21.39% | 9 | Aug 7, 2024 | |
| LMAT LeMaitre Vascular | Maintains: Outperform | $79 → $82 | $86.34 | -5.03% | 6 | Aug 2, 2024 | |
| OPCH Option Care Health | Maintains: Outperform | $38 → $40 | $32.46 | +23.23% | 9 | Aug 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $100 | $96.76 | +3.35% | 12 | Jul 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $38 | $25.08 | +51.55% | 12 | Jul 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $39.62 | - | 6 | May 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $5.88 | - | 1 | Jul 27, 2021 |
Lifecore Biomedical
Aug 28, 2024
Downgrades: Market Perform
Price Target: n/a
Current: $4.84
Upside: -
U.S. Physical Therapy
Aug 15, 2024
Maintains: Outperform
Price Target: $122 → $108
Current: $83.64
Upside: +29.12%
VerifyMe
Aug 14, 2024
Maintains: Outperform
Price Target: $2 → $1.5
Current: $1.34
Upside: +11.94%
Haemonetics
Aug 9, 2024
Maintains: Outperform
Price Target: $107 → $108
Current: $73.94
Upside: +46.06%
Anika Therapeutics
Aug 9, 2024
Maintains: Outperform
Price Target: $37
Current: $24.59
Upside: +50.47%
ModivCare
Aug 9, 2024
Upgrades: Outperform
Price Target: $35
Current: $30.00
Upside: +16.67%
OPKO Health
Aug 8, 2024
Maintains: Outperform
Price Target: $1.5 → $2.25
Current: $1.59
Upside: +41.51%
Henry Schein
Aug 7, 2024
Maintains: Outperform
Price Target: $92 → $82
Current: $67.55
Upside: +21.39%
LeMaitre Vascular
Aug 2, 2024
Maintains: Outperform
Price Target: $79 → $82
Current: $86.34
Upside: -5.03%
Option Care Health
Aug 1, 2024
Maintains: Outperform
Price Target: $38 → $40
Current: $32.46
Upside: +23.23%
Jul 16, 2024
Maintains: Outperform
Price Target: $100
Current: $96.76
Upside: +3.35%
Jul 8, 2024
Maintains: Outperform
Price Target: $38
Current: $25.08
Upside: +51.55%
May 30, 2024
Downgrades: Market Perform
Price Target: n/a
Current: $39.62
Upside: -
Jul 27, 2021
Downgrades: Market Perform
Price Target: n/a
Current: $5.88
Upside: -